Navigation Links
AMA Foundation Honors Hawaii Physician
Date:11/12/2007

HONOLULU, Nov. 12 /PRNewswire-USNewswire/ -- Dileep G. Bal, M.D., received the 2007 AMA Foundation Award for Health Education. Presented by the AMA Foundation, the award recognizes physicians who have led, developed or implemented professional and public health education activities. The award was presented to Dr. Bal, a district health officer for the island of Kauai, Saturday during the opening session of the AMA's semi-annual policy-making meeting.

"We are pleased to present Dr. Bal with this award. His dedication to public health, medical and social issues is admirable and a real asset to the medical community," said AMA President Ron Davis, M.D.

Dr. Bal has long been involved in calling attention to the dangers of smoking and making strides to curb its use among Americans. He played an instrumental role in establishing one of the largest tobacco use prevention and cessation programs, which has been widely acclaimed for its innovation and effectiveness. For more than two decades, Dr. Bal served as chief of the Cancer Control Branch within the California Department of Health Services and was responsible for implementing California's tobacco control efforts beginning in 1988.

During his time in California, Dr. Bal was also a clinical professor at the University of California at Davis School of Medicine, where he was active in teaching and research programs. He has also served as principal investigator on major cancer prevention and control projects for the National Cancer Institute and the Centers for Disease Control and Prevention. Dr. Bal is a frequent speaker both nationally and internationally on public health, medical and social issues, and was recently the commencement speaker at Brown University School of Medicine.

As the philanthropic arm of the American Medical Association, the AMA Foundation is committed to supporting programs in a broad range of health-related areas. For more information, please visit

SOURCE American Medical Association
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. National Patient Safety Foundation Partners with Vocera Communications
2. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
3. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
4. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
5. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
6. Judge Rules That Florida Disease Management Program Serving 8,000 HIV/AIDS Patients Should Be Re-bid, Says AIDS Healthcare Foundation
7. The Tug McGraw Foundation Announces 2007 Fundraising Gala
8. The Arthur M. Blank Family Foundation Pushes for Pre-K Expansion in Georgia
9. Cipla, Tell the Truth; AIDS Healthcare Foundation Launches New Ad Campaign
10. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
11. Exceptional Childrens Foundation Merger with Kayne Eras Center Creates One of States Most Comprehensive Nonprofits Serving the Disabled
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine Technology:Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases 2Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 2Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 3Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 4Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 5Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 6